Non-Segmental Vitiligo Research Trial (63 Weeks)

Adults aged 18 years or older with a clinical diagnosis of non-segmental vitiligo (bilateral and symmetrical loss of skin pigment), may qualify to participate. Individuals must have a loss of skin pigment on the face and body, along with at least one active vitiligo lesion. Individuals must agree to discontinue all agents used to treat vitiligo from screening through the final safety follow-up visit.

Participants will receive investigational topical medication (active study drug) or placebo, during the initial treatment period. In the extension period, all subjects will receive active study drug. Study medication and study-related procedures will be provided at no cost. Reimbursement for study-related expenses will also be provided.

Study participation will last about 63 weeks and involve about 11 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Vitiligo
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more